BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 33609664)

  • 1. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents.
    Takahashi Y; Takakura Y
    Pharmacol Ther; 2023 Feb; 242():108352. PubMed ID: 36702209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.
    Surman M; Drożdż A; Stępień E; Przybyło M
    Curr Pharm Des; 2019; 25(2):132-154. PubMed ID: 30848183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel platform for cancer therapy using extracellular vesicles.
    Tominaga N; Yoshioka Y; Ochiya T
    Adv Drug Deliv Rev; 2015 Dec; 95():50-5. PubMed ID: 26482189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles in the Development of Cancer Therapeutics.
    Sun H; Burrola S; Wu J; Ding WQ
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
    Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
    Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles as drug vectors for precise cancer treatment.
    Cao XH; Liang MX; Wu Y; Yang K; Tang JH; Zhang W
    Nanomedicine (Lond); 2021 Jul; 16(17):1519-1537. PubMed ID: 34011162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
    Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
    Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
    Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
    ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.